Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fengre Ganmao Keli is a Traditional Chinese Medicine (TCM) granule formulation developed and manufactured by Shandong Kongfu Pharmaceutical. It is specifically indicated for the treatment of the wind-heat type of common cold, which is characterized by symptoms such as fever, headache, cough, dry mouth, and sore throat. The product is composed of a standardized mixture of herbal extracts, typically including *Isatidis Radix* (Banlangen), *Lonicerae Japonicae Flos* (Jinyinhua), and *Forsythiae Fructus* (Lianqiao). These ingredients are traditionally used in TCM to clear heat, resolve the exterior, and detoxify the body. As an approved pharmaceutical product in China, it is widely utilized for the symptomatic relief of upper respiratory tract infections that present with a wind-heat pattern.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fengre ganmao keli.